Natural Hormone Replacement Therapy for Men and Women
Video taken from the channel: iprogressivemed
Making Sense of Hormone Replacement Therapy & Breast Cancer Risk
Video taken from the channel: MD Anderson Cancer Center
Women’s Wellness: Hormone therapy and Alzheimer’s disease
Video taken from the channel: Mayo Clinic
Why Women Are More Likely to Develop Alzheimer’s?
Video taken from the channel: Dr. Zulfiquar Ahmed
Does hormone therapy increase risk of Alzheimer’s?
Video taken from the channel: DrAllmen
Do Hormones Really Affect Your Memory? | Brain Talks | Being Patient
Video taken from the channel: Being Patient Alzheimer’s
Estrogen Patch May Reduce Risk Of Alzheimer’s
Video taken from the channel: Wochit News
Estrogen Can Substantially Decrease the Risk of Alzheimer’s Alzheimer’s disease is a concern for many menopausal women, and yet most do not consider taking hormone replacement therapy, even though estrogen can significantly delay Alzheimer’s. Barb DePree, MD, NCMP,MMM 27 Mar 2019 Your Health. In spite of everything you read and the drugs that are being tried —both those advertised and those requiring a prescription—nothing significantly delays or prevents Alzheimer’s disease except estrogen, which can decrease the risk of Alzheimer’s disease by up to 50 percent.
There’s new evidence that a woman’s levels of female sex hormones, including estrogen and progesterone, can influence her risk of Alzheimer’s and other forms of dementia. Estrogen and Dementia Previous studies have made it clear that women stand a higher risk of developing Alzheimer’s: Women aged 65 or older stand a one in six chance of developing the disease when compared to one in 11 men. These results were a disappointment since earlier studies had reported that women taking estrogen hormone therapy had a substantially lower risk of developing dementia. In preclinical studies, estrogen was shown to improve energy production, reduce oxidative stress, increase brain cell survival during damage, enhance the release of protective chemicals, and.
On a positive note, a large epidemiological study found that estrogen given early in menopause reduced Alzheimer’s risk, and results from a small cohort indicated that early treatment with the hormone may have slowed amyloid accumulation. However, another study found that early treatment with the hormone shrank the brain. New research has found a link between dementia and estrogen levels — the more estrogen a woman receives from pregnancy, for example, the less the risk of. Women who took estrogen in mid-life but not in late life had a 26 percent decreased risk of developing dementia in old age compared with women who had never taken estrogen at any age, whereas women who took estrogen in late life but not in mid-life had a 48 percent increased risk of dementia compared with non-estrogen-taking women.
The women who took the estrogen had an average 22% increase in cerebral blood flow compared with the placebo group. The largest increase was in the left temporal region, which is typically affected. The exclusive use of vaginal estrogen was not associated with an increased risk for Alzheimer’s.
For women who initiated HRT after the age of 60, the use of HRT (estrogen and progestogen or estrogen alone) was associated with a 15-38% increase in risk for Alzheimer’s disease compared to women who did not use HRT.
List of related literature:
|from Brunner & Suddarth’s Textbook of Medical-surgical Nursing|
|from Foundations of Maternal-Newborn and Women’s Health Nursing|
|from Textbook of Family Medicine E-Book|
|from It’s My Ovaries, Stupid!|
|from Principles and Practice of Geriatric Medicine|
|from Guccione’s Geriatric Physical Therapy E-Book|
|from Medical Care of Cancer Patients|
|from Textbook of Oral and Maxillofacial Surgery|
|from Encyclopedia of Behavioral Neuroscience|
|from Screaming to be Heard: Hormonal Connections Women Suspect… and Doctors Still Ignore|